In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways.
about
Targeted drugs in small-cell lung cancerCan microRNAs improve the management of lung cancer patients? A clinician's perspectiveTumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer"Self-assisted" amoeboid navigation in complex environmentsTumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changesExpression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer.Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanismsGlial progenitors as targets for transformation in glioma.Akt-mediated phosphorylation of XLF impairs non-homologous end-joining DNA repair.Fibroblasts contribute to melanoma tumor growth and drug resistance.NHE9 induces chemoradiotherapy resistance in esophageal squamous cell carcinoma by upregulating the Src/Akt/β-catenin pathway and Bcl-2 expression.Aberrant LRP16 protein expression in primary neuroendocrine lung tumors.Targeting the stromal fibroblasts: a novel approach to melanoma therapy.Bid-overexpression regulates proliferation and phosphorylation of Akt and MAPKs in response to etoposide-induced DNA damage in hepatocellular carcinoma cellsEstablishment of animal model for the analysis of cancer cell metastasis during radiotherapyBmi-1 induces radioresistance in MCF-7 mammary carcinoma cells.Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer.Targeting the Mammalian Target of Rapamycin in Lung Cancer.Update on new drugs in small cell lung cancer.Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma.Signal control through Raf: in sickness and in health.Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers.The Biological Role of PI3K Pathway in Lung Cancer.Chemotherapy Resistance in Lung Cancer.Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway.Staurosporine analogs promote distinct patterns of process outgrowth and polyploidy in small cell lung carcinoma cells.Carbonic anhydrase II mediates malignant behavior of pulmonary neuroendocrine tumors.The Phosphatidylinositol 3-kinase/Akt Signaling Pathway in Neuroendocrine Tumors.NCAM polysialylation during adherence transitions: live cell monitoring using an antibody-mimetic EGFP-endosialidase and the viability dye DRAQ7.Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells.Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad.PPARgamma activation extinguishes smoking carcinogen by inhibiting NNK-mediated proliferation.Transcriptional changes in U343 MG-a glioblastoma cell line exposed to ionizing radiation.Genotype-phenotype relationships in a mouse model for human small-cell lung cancer.Notch1 controls cell chemoresistance in small cell lung carcinoma cellsRegulation of FBXO4-mediated ICAM-1 protein stability in metastatic breast cancer.Helicobacter pylori CagA protein activates Akt and attenuates chemotherapeutics-induced apoptosis in gastric cancer cells.CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer.miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2.
P2860
Q26767017-D03C4CCA-7C26-4377-A67F-B5637B006C0CQ26999304-DC2764C8-4F75-4579-A7F1-882F625D162DQ28396304-92CA8504-B61C-4771-9771-11622BBF206BQ28476441-2ACD77DD-0FEE-46DE-8B8F-E5E2114C390CQ28539958-26D6E59B-571F-407A-83BB-F306C55C8752Q33268089-E007123D-FBD5-4688-9D55-3F27DF4837F2Q34013850-FDABB7BC-0209-4C16-9DDB-DEA2665CEF53Q34534169-0D218266-D27E-46B4-A712-A8EBD7549B65Q34735661-89BFD26D-3E44-49B8-8D49-EDC6B600EED8Q35108163-3192DFAE-ABFD-4E9D-B362-3E431CA38595Q35607701-D978279C-548B-4945-8AA1-2F5FD9E86D1EQ35828588-4D0ABA0A-C032-4639-8CED-B2CDC6936C0BQ35919043-9F1D196B-9AB6-48B9-B439-E0EA543B94C6Q36334912-547512CF-6AFF-4D06-AB04-E58E231CD1C3Q36337903-4832D96C-82B0-470E-AE9D-5D385D61D567Q36384068-50603B68-0E46-4E7F-9A76-36B3AFC3692FQ36642124-EF67B4C3-076C-467B-97BD-07357C0322CEQ37463325-E24E35C0-64A3-435C-AAF4-631AB3990449Q37741531-261D140F-C5EA-413F-ACB5-6F2E0DFBC751Q37851992-FD9CFB80-6A26-46EE-8E71-322E0E8DD5CDQ37941807-ACAA0AFE-AC10-4AA5-A369-14320D1F4607Q37965017-A90BC08E-7AD8-4D8A-AAE4-872E01449CBCQ38073827-0958D3F5-8285-426E-B145-ADF51CE97C9EQ38166599-3CE5FEF1-6BDF-490C-B23E-C3328CD13DB1Q38669287-8F829671-F56B-4A5E-AC8F-F70F26BBE6C0Q38739223-E0AE57A1-19F7-493F-B5DA-B249CAFD7BECQ38930827-D9C6FBAB-B01D-46BE-BAD4-6EDE52FCD3ECQ38975596-98428170-8F6D-49B3-A98B-A60D5CADD87CQ39042894-7BF4BEA5-8445-4AF0-8780-7D3031AB2470Q39146371-39D6E252-0671-4130-89CF-383F1A5FDB79Q39350206-D5A05106-14DC-4324-A52C-DD049181E95FQ39426084-C4FC0F24-FAE6-4BE7-A405-DBD88F1C9D49Q39864032-431ECFD5-F4D5-49DF-B9AA-4971D5DD64FBQ39875156-24440427-642D-4CB7-88EB-F687D56B6C6CQ40251356-F0A0C934-A888-400B-8D13-1BA76CF5DCDEQ41862980-E807C0F4-7742-4D2C-8A93-3BE1DB281BB0Q43465643-223B6FD2-C82A-46C3-9AC2-1D9860436AEDQ47645605-7D0FA2F1-66E7-4D90-AEAB-99950C4394E0Q52728031-6017A796-0E68-4711-A787-64B4E8D0A2D8Q55015657-24C889C4-594A-4562-9AC5-613CD57463F0
P2860
In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
In vitro chemo- and radio-resi ...... f AKT and MAP kinase pathways.
@en
In vitro chemo- and radio-resi ...... f AKT and MAP kinase pathways.
@nl
type
label
In vitro chemo- and radio-resi ...... f AKT and MAP kinase pathways.
@en
In vitro chemo- and radio-resi ...... f AKT and MAP kinase pathways.
@nl
prefLabel
In vitro chemo- and radio-resi ...... f AKT and MAP kinase pathways.
@en
In vitro chemo- and radio-resi ...... f AKT and MAP kinase pathways.
@nl
P2093
P356
P1433
P1476
In vitro chemo- and radio-resi ...... f AKT and MAP kinase pathways.
@en
P2093
Alison C Kraus
Anja Wimmel
Hannah Specht
Ines Ferber
Juergen Schlegel
Marcus Schuermann
Markus W Gross
Sven-Oliver Bachmann
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205939
P407
P577
2002-12-01T00:00:00Z